Media Highlights
Patients Over 80 Still Benefit From Treatment for AML Blood Cancer
May 14, 2024
Dr. Justin Watts discusses his research that shows seniors over 80 with acute myeloid leukemia can safely and effectively take the VEN-HMA regimen, which is the standard of care for older AML patients and those who are ineligible to receive intensive chemotherapy.
